Tipping Growth Inhibition into Apoptosis by Combining Treatment with MDM2 and WIP1 Inhibitors in p53(WT) Uterine Leiomyosarcoma

SIMPLE SUMMARY: Uterine Leiomyosarcoma (uLMS) is a rare (0.8 per 100,000 women), aggressive cancer that predominantly affects post-menopausal women. Prognosis for these women is poor, with relapse following primary treatment occurring in up to 70% of cases. For women with recurrent or advanced uLMS,...

Descripción completa

Detalles Bibliográficos
Autores principales: Chamberlain, Victoria, Drew, Yvette, Lunec, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750798/
https://www.ncbi.nlm.nih.gov/pubmed/35008180
http://dx.doi.org/10.3390/cancers14010014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750798/
https://www.ncbi.nlm.nih.gov/pubmed/35008180
http://dx.doi.org/10.3390/cancers14010014

Ejemplares similares